Literature DB >> 28973537

Utilization, Cost, and Outcome of Branded vs Compounded 17-Alpha Hydroxyprogesterone Caproate in Prevention of Preterm Birth.

Inbar Fried1, Andrew L Beam1, Isaac S Kohane1, Nathan P Palmer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28973537      PMCID： PMC5820707          DOI： 10.1001/jamainternmed.2017.5017

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  5 in total

1.  Unintended consequences--the cost of preventing preterm births after FDA approval of a branded version of 17OHP.

Authors:  Joanne Armstrong
Journal:  N Engl J Med       Date:  2011-03-16       Impact factor: 91.245

Review 2.  The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.

Authors:  Aaron S Kesselheim; Jerry Avorn; Ameet Sarpatwari
Journal:  JAMA       Date:  2016 Aug 23-30       Impact factor: 56.272

3.  Estimated effect of 17 alpha-hydroxyprogesterone caproate on preterm birth in the United States.

Authors:  Joann R Petrini; William M Callaghan; Mark Klebanoff; Nancy S Green; Eve M Lackritz; Jennifer L Howse; Richard H Schwarz; Karla Damus
Journal:  Obstet Gynecol       Date:  2005-02       Impact factor: 7.661

4.  Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.

Authors:  Paul J Meis; Mark Klebanoff; Elizabeth Thom; Mitchell P Dombrowski; Baha Sibai; Atef H Moawad; Catherine Y Spong; John C Hauth; Menachem Miodovnik; Michael W Varner; Kenneth J Leveno; Steve N Caritis; Jay D Iams; Ronald J Wapner; Deborah Conway; Mary J O'Sullivan; Marshall Carpenter; Brian Mercer; Susan M Ramin; John M Thorp; Alan M Peaceman; Steven Gabbe
Journal:  N Engl J Med       Date:  2003-06-12       Impact factor: 91.245

5.  Pregnancy outcomes of women receiving compounded 17 α-hydroxyprogesterone caproate for prophylactic prevention of preterm birth 2004 to 2011.

Authors:  Baha M Sibai; Niki B Istwan; Beverly Palmer; Gary J Stanziano
Journal:  Am J Perinatol       Date:  2012-05-10       Impact factor: 1.862
  5 in total
  1 in total

1.  Medication utilization in children born preterm in the first two years of life.

Authors:  Jonathan C Levin; Andrew L Beam; Kathe P Fox; Kenneth D Mandl
Journal:  J Perinatol       Date:  2021-02-05       Impact factor: 2.521
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.